Cargando…
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
Breast cancer is the most frequently diagnosed malignancy in patients worldwide and the main cause of cancer-related death. Though still incurable, metastatic breast cancer’s prognosis has been considerably improved in the past 10 years due to the introduction of new targeted agents, such as immune...
Autores principales: | Nunes Filho, Paulo, Albuquerque, Caroline, Pilon Capella, Mariana, Debiasi, Marcio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260715/ https://www.ncbi.nlm.nih.gov/pubmed/36917399 http://dx.doi.org/10.1007/s40487-023-00224-9 |
Ejemplares similares
-
An overview of immune checkpoint inhibitors in breast cancer
por: Miglietta, Federica, et al.
Publicado: (2020) -
Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020) -
The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review
por: Araji, Ghada, et al.
Publicado: (2021) -
Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic
por: Pang, Steph A., et al.
Publicado: (2023) -
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
por: Profili, Nicia I., et al.
Publicado: (2023)